Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Real Life Management of Chronic Urticaria: Multicenter and Cross Sectional Study on Patients and Dermatologists in Iran Publisher Pubmed



Firooz A1 ; Akhlaghi A2 ; Golbidi P3 ; Pourjafari M3 ; Abdollahimajd F4 ; Azimi H5 ; Banihashemi M6 ; Darvish Damavandi F7 ; Erfani AR8 ; Farajzadeh S9 ; Ghassemi M10 ; Gheisari M4 ; Hamedpour K11 ; Handjani F12 Show All Authors
Authors
  1. Firooz A1
  2. Akhlaghi A2
  3. Golbidi P3
  4. Pourjafari M3
  5. Abdollahimajd F4
  6. Azimi H5
  7. Banihashemi M6
  8. Darvish Damavandi F7
  9. Erfani AR8
  10. Farajzadeh S9
  11. Ghassemi M10
  12. Gheisari M4
  13. Hamedpour K11
  14. Handjani F12
  15. Hashemi SA13
  16. Herizchi H14
  17. Iraji F15
  18. Jalili H16
  19. Khatami A1
  20. Lajevardi V17
  21. Mansouri P18
  22. Masjedi H19
  23. Mehrian P20
  24. Mohammadi S21
  25. Mohebbi A22
  26. Namazi N23
  27. Nasiri Kashani M1
  28. Radmehr A24
  29. Safar F25
  30. Saffarian Z26
  31. Saneei S24
  32. Seirafi H27
  33. Taheri S28
  34. Yazdanpanah MJ29
  35. Zaboli Nejad N30
  36. Naseri M31
  37. Peiravi P32
  38. Teymori G33

Source: Dermatologic Therapy Published:2019


Abstract

Recently, advances in understanding the etiology of urticaria and updates of diagnostic and therapeutic management guidelines have drawn attention to chronic urticaria (CU) morbidity. The present study aimed to evaluate Iranian dermatologists' practice and real life management of CU patients. A total of 35 dermatologists and 443 patients were included in the study. Number of female patients was 321 (72.5%). Mean (standard deviation) age of the study patients was 38 (13) years and the median (inter quartile range) of disease duration was 12 (6–48) months. Severity of patients' symptoms was mild for 32.1%, moderate for 38.7%, severe for 18.8%, and 10.4% of them had no evident signs or symptoms. The most common diagnostic methods were physical examination (96.6%), differential blood count (83.5%), erythrocyte sedimentation rate (77.4%), and C-reactive protein (62.8%). The number of dermatologists prescribed nonsedating antihistamines (nsAH) in regular dose and high dose mono therapy were 26 (74%) and 6 (17%), respectively. About 66% of dermatologists were familiar with British Association of Dermatologists (BAD) guideline. The most common first-line treatment for CU by Iranian dermatologists was nonsedating antihistamines in regular or high doses. The real-life management of patients with CU in Iran was in accordance with the available practice guidelines. © 2018 Wiley Periodicals, Inc.
Other Related Docs
8. Quality of Life and Related Factors in Patients With Chronic Urticaria in Kurdistan Province, Scientific Journal of Kurdistan University of Medical Sciences (2020)
9. Platelet Count and Ige Level in Chronic Idiopathic Urticaria: A Case-Control Study, Recent Advances in Inflammation and Allergy Drug Discovery (2022)
11. Vitamin D Deficiency in Chronic Idiopathic Urticaria, Iranian Journal of Allergy# Asthma and Immunology (2015)
12. Chronic Urticaria in Pregnancy: Physiologic and Hormonal Background for an Immune Skin Disease, Journal of South Asian Federation of Obstetrics and Gynaecology (2024)